Pharmacological treatment for substance use disorder: A systematic review

Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention

Volkow, N. D., & Blanco, C. (2023) · World psychiatry · doi:10.1002/wps.21073 · Cited by 503 · see citing works

Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial

Klausen, M. K., Jensen, M. E., Møller, M., Le Dous, N., Jensen, A.-M. Ø., Zeeman, V. A., Johannsen, C.-F., Lee, A., Thomsen, G. K., Macoveanu, J., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.159863 · Cited by 262 · see citing works

Treatment of stimulant use disorder: A systematic review of reviews

Ronsley, C., Nolan, S., Knight, R., Hayashi, K., Klimas, J., Walley, A., Wood, E., & Fairbairn, N. (2020) · PLOS ONE · doi:10.1371/journal.pone.0234809 · Cited by 222 · see citing works

Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial

Freeman, T. P., Hindocha, C., Baio, G., Shaban, N. D. C., Thomas, E. M., Astbury, D., Freeman, A. M., Lees, R., Craft, S., Morrison, P. D., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30290-x · Cited by 202 · see citing works

Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial

Anton, R. F., Latham, P., Voronin, K., Book, S., Hoffman, M., Prisciandaro, J., & Bristol, E. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0249 · Cited by 186 · see citing works

Pharmacotherapy for Cocaine Use Disorder—a Systematic Review and Meta-analysis

Chan, B., Kondo, K., Freeman, M., Ayers, C., Montgomery, J., & Kansagara, D. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05074-8 · Cited by 150 · see citing works

Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial

Grodin, E. N., Bujarski, S., Towns, B., Burnette, E. M., Nieto, S. J., Lim, A. C., Lin, J. W., Miotto, K. A., Gillis, A. J., Irwin, M. R., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01478-5 · Cited by 79 · see citing works

Treatment interventions to maintain abstinence from alcohol in primary care: systematic review and network meta-analysis

Cheng, H., McGuinness, L. A., Elbers, R. G., MacArthur, G. J., Taylor, A., McAleenan, A., Dawson, S., López-López, J. A., Higgins, J. P. T., Cowlishaw, S., et al. (2020) · BMJ · doi:10.1136/bmj.m3934 · Cited by 78 · see citing works

Efficacy and tolerability of baclofen in a U.S. community population with alcohol use disorder: A dose-response, randomized, controlled trial

Garbutt, J. C., Kampov-Polevoy, A. B., Pedersen, C., Stansbury, M., Jordan, R., Willing, L., & Gallop, R. J. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01055-w · Cited by 68 · see citing works

Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo‐controlled trial

Mongeau‐Pérusse, V., Brissette, S., Bruneau, J., Conrod, P., Dubreucq, S., Gazil, G., Stip, É., & Jutras‐Aswad, D. (2021) · Addiction · doi:10.1111/add.15417 · Cited by 64 · see citing works

Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta‐analysis

Ray, L. A., Green, R., Roche, D. J. O., Magill, M., & Bujarski, S. (2019) · Addiction Biology · doi:10.1111/adb.12747 · Cited by 59 · see citing works

Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials

Lim, J., Farhat, I., Douros, A., & Panagiotoglou, D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266142 · Cited by 56 · see citing works

Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial

Collins, S. E., Duncan, M. H., Saxon, A. J., Taylor, E. M., Mayberry, N., Merrill, J. O., Hoffmann, G., Clifasefi, S. L., & Ries, R. K. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30489-2 · Cited by 55 · see citing works

Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults

McClure, E. A., Baker, N. L., Hood, C. O., et al. (2019) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntz170 · Cited by 49 · see citing works

Questions and answers about conducting systematic reviews in sport and exercise psychology

Gunnell, K., Poitras, V. J., & Tod, D. (2020) · International Review of Sport and Exercise Psychology · doi:10.1080/1750984x.2019.1695141 · Cited by 45 · see citing works

Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta‐analysis of randomised controlled trials

Acheson, L. S., Williams, B. H., Farrell, M., McKetin, R., Ezard, N., & Siefried, K. J. (2022) · Drug and Alcohol Review · doi:10.1111/dar.13511 · Cited by 45 · see citing works

Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis

Bahji, A., Meyyappan, A. C., Hawken, E. R., & Tibbo, P. G. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103295 · Cited by 43 · see citing works

Efficacy and Safety of Varenicline for Adolescent Smoking Cessation

Gray, K. M., Baker, N. L., McClure, E. A., Tomko, R. L., Squeglia, L. M., Saladin, M. E., & Carpenter, M. J. (2019) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2019.3553 · Cited by 42 · see citing works

Quetiapine treatment for cannabis use disorder

Mariani, J. J., Pavlicová, M., Choi, C. J., Basaraba, C. N., Carpenter, K. M., Mahony, A. L., Brooks, D. J., Bisaga, A. M., Naqvi, N. H., Nunes, E. V., et al. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108366 · Cited by 38 · see citing works

Treatment of amphetamine abuse/use disorder: a systematic review of a recent health concern

Khoramizadeh, M., Effatpanah, M., Mostaghimi, A., Rezaei, M., Mahjoub, A., & Shishehgar, S. (2019) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-019-00282-3 · Cited by 33 · see citing works

Pharmacological interventions on smoking cessation: A systematic review and network meta-analysis

Shang, X., Guo, K., Fenfen, E., Deng, X., Wang, Y., Wang, Z., Wu, Y., Xu, M., Yang, C., Li, X., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1012433 · Cited by 33 · see citing works

Ibudilast attenuates alcohol cue–elicited frontostriatal functional connectivity in alcohol use disorder

Burnette, E. M., Ray, L. A., Irwin, M. R., & Grodin, E. N. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14696 · Cited by 32 · see citing works

Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analysis of mechanism of actions.

Garel, N., McAnulty, C., Greenway, K. T., Lespérance, P., Miron, J., Rej, S., Richard‐Devantoy, S., & Jutras‐Aswad, D. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109606 · Cited by 32 · see citing works

Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder

Kranzler, H. R., Morris, P. E., Pond, T., Crist, R. C., Kampman, K. M., Hartwell, E. E., & Lynch, K. G. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-020-00945-9 · Cited by 31 · see citing works

Varenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial

McRae‐Clark, A. L., Gray, K. M., Baker, N. L., Sherman, B. J., Squeglia, L. M., Sahlem, G. L., Wagner, A. M., & Tomko, R. L. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109111 · Cited by 30 · see citing works

Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder

Hua, D. Y.-H., Hindocha, C., Baio, G., Lees, R., Shaban, N. D. C., Morgan, C. J. A., Mofeez, A., Curran, H. V., & Freeman, T. P. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02410-9 · Cited by 30 · see citing works

Randomized placebo-controlled trial of galantamine in individuals with cocaine use disorder

DeVito, E. E., Carroll, K. M., Babuscio, T. A., et al. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.08.009 · Cited by 24 · see citing works

PPARγ activation by pioglitazone does not suppress cravings for alcohol, and is associated with a risk of myopathy in treatment seeking alcohol dependent patients: a randomized controlled proof of principle study

Schwandt, M. L., Diazgranados, N., Umhau, J. C., Kwako, L. E., George, D. T., & Heilig, M. A. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05540-w · Cited by 24 · see citing works

Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates

Terasaki, D., Loh, R. M., Cornell, A., Taub, J., & Thurstone, C. (2022) · Addiction Science & Clinical Practice · doi:10.1186/s13722-022-00345-y · Cited by 24 · see citing works

N-acetylcysteine as an adjunctive treatment for smoking cessation: a randomized clinical trial

Machado, R. C. B. R., Vargas, H. O., Baracat, M. M., Urbano, M. R., Verri, W. A., Jr., Porcu, M., & Nunes, S. O. V. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2019-0753 · Cited by 21 · see citing works

Cannabidiol effects on cognition in individuals with cocaine use disorder: Exploratory results from a randomized controlled trial

Rizkallah, É., Mongeau‐Pérusse, V., Lamanuzzi, L., Castenada-Ouellet, S., Stip, É., Juteau, L.-C., Brissette, S., Bruneau, J., Dubreucq, S., & Jutras‐Aswad, D. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173376 · Cited by 21 · see citing works

Double‐Blind Placebo‐Controlled Trial of Galantamine for Methadone‐Maintained Individuals With Cocaine Use Disorder: Secondary Analysis of Effects on Illicit Opioid Use

Carroll, K. M., DeVito, E. E., Yip, S. W., Nich, C., & Sofuoglu, M. (2019) · American Journal on Addictions · doi:10.1111/ajad.12904 · Cited by 20 · see citing works

Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder

Karl, D., Bumb, J. M., Bach, P., Dinter, C., Koopmann, A., Hermann, D., Mann, K. F., Kiefer, F., & Vollstädt‐Klein, S. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05842-7 · Cited by 20 · see citing works

Treating alcohol dependence with an abuse and misuse deterrent formulation of sodium oxybate: Results of a randomised, double-blind, placebo-controlled study

Guiraud, J., Addolorato, G., Aubin, H.-J., Batel, P., de Bejczy, A., Caputo, F., Goudriaan, A. E., Gual, A., Lesch, O., Maremmani, I., et al. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.06.003 · Cited by 20 · see citing works

Exogenous progesterone for cannabis withdrawal in women: Feasibility trial of a novel multimodal methodology

Sherman, B. J., Caruso, M. A., & McRae‐Clark, A. L. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.01.008 · Cited by 18 · see citing works

Pilot randomized placebo‐controlled clinical trial of high‐dose gabapentin for alcohol use disorder

Mariani, J. J., Pavlicová, M., Basaraba, C. N., Mamczur, A. K., Brooks, D. J., Bisaga, A. M., Carpenter, K. M., Nunes, E. V., & LEVIN, F. R. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14648 · Cited by 18 · see citing works

Effects of topiramate on the association between affect, cannabis craving, and cannabis use in the daily life of youth during a randomized clinical trial

Emery, N. N., Carpenter, R. W., Meisel, S. N., & Miranda, R. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05925-5 · Cited by 18 · see citing works

Citalopram for treatment of cocaine use disorder: A Bayesian drop-the-loser randomized clinical trial

Suchting, R., Green, C. E., de Dios, C., Vincent, J. N., Moeller, F. G., Lane, S. D., & Schmitz, J. M. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109054 · Cited by 18 · see citing works

Evaluating N-acetylcysteine for early and end-of-treatment abstinence in adult cigarette smokers

McClure, E. A., Wahlquist, A. E., Tomko, R. L., Baker, N. L., Carpenter, M. J., Bradley, E., Cato, P. A., Gipson, C. D., & Gray, K. M. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108815 · Cited by 16 · see citing works

A Randomized Controlled Trial Examining the Effects of Intranasal Oxytocin on Alcohol Craving and Intimate Partner Aggression among Couples

Flanagan, J. C., Nietert, P. J., Sippel, L., Jarnecke, A. M., Kirby, C., Hogan, J. N., Massa, A. A., Brower, J., Back, S. E., & Parrott, D. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.06.011 · Cited by 16 · see citing works

Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials

Vuilleumier, C., Scherbaum, N., Bonnet, U., & Roser, P. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.867878 · Cited by 16 · see citing works

Dose‐dependent naloxone‐induced morphine withdrawal symptoms in opioid‐dependent males—a double‐blinded, randomized study

Weisshaar, S., Brandt, L., Litschauer, B., Sheik‐Rezaei, S., Moser, L., Nirnberger, G., Kühberger, E., Bauer, U., Firbas, C., Gouya, G., et al. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14271 · Cited by 13 · see citing works

A Randomized, Double‐Blind, Placebo‐Controlled Trial of Citicoline in Patients with Alcohol Use Disorder

Brown, E. S., Enkevort, E. A. V., Kulikova, A., Escalante, C., Nakamura, A., Ivleva, E. I., & Holmes, T. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13928 · Cited by 12 · see citing works

The effects of pharmacological interventions on smoking cessation in people with alcohol dependence: A systematic review and meta‐analysis of nine randomized controlled trials

Guo, K., Li, J., Li, J.-Y., Chen, N., Li, Y.-F., Yang, K.-H., & Li, X.-X. (2021) · International journal of clinical practice · doi:10.1111/ijcp.14594 · Cited by 12 · see citing works

Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double‐blind, placebo‐controlled trial

Kotajima‐Murakami, H., Takano, A., Hirakawa, S., Ogai, Y., Funada, D., Tanibuchi, Y., Ban, E., Kikuchi, M., Tachimori, H., Maruo, K., et al. (2022) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12232 · Cited by 12 · see citing works

A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis

Blevins, D., Seneviratne, C., Wang, X.-Q., Johnson, B. A., & Ait‐Daoud, N. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109074 · Cited by 11 · see citing works

Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels

Nieto, S. J., Enders, C. K., Witkiewitz, K. A., O’Malley, S. S., & Ray, L. A. (2022) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14953 · Cited by 10 · see citing works

Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: a randomized trial

Schacht, J. P., Hoffman, M., Chen, B. H., & Anton, R. F. (2021) · The Pharmacogenomics Journal · doi:10.1038/s41397-021-00250-8 · Cited by 9 · see citing works

Naltrexone moderates the association of alcohol use and affect among adolescent drinkers in daily life

Carpenter, R. W., Emery, N. N., Meisel, S. N., & Miranda, R. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14768 · Cited by 9 · see citing works

The effects of nalmefene on the impulsive and reflective system in alcohol use disorder: A resting-state fMRI study

Grundinger, N., Gerhardt, S., Karl, D., Mann, K. F., Kiefer, F., & Vollstädt‐Klein, S. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06137-1 · Cited by 9 · see citing works

Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder

Mills, L., Dunlop, A. J., Montebello, M. E., Copeland, J., Bruno, R., Jefferies, M., McGregor, I. S., & Lintzeris, N. (2022) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-022-00493-z · Cited by 9 · see citing works

Results of a randomized, double-blind, placebo-controlled trial of lorcaserin in cocaine use disorder

McCann, D. J., Chen, H. H., Devine, E. G., Gyaw, S., & Ramey, T. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.111063 · Cited by 9 · see citing works

Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol use disorder endophenotypes

Johnson, B. A., Alho, H., Addolorato, G., Lesch, O. M., Chick, J., Liu, L., & Schuyler, V. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.06.001 · Cited by 9 · see citing works

Clinical moderators of response to nalmefene in a randomized-controlled trial for alcohol dependence: An exploratory analysis

Hashimoto, N., Habu, H., Takao, S., Sakamoto, S., Okahisa, Y., Matsuo, K., Takaki, M., Kishi, Y., & Yamada, N. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109365 · Cited by 8 · see citing works

The therapeutic effect of N‐acetylcysteine as an add‐on to methadone maintenance therapy medication in outpatients with substance use disorders: A randomized, double‐blind, placebo‐controlled clinical trial

Padoei, F., Mamsharifi, P., Hazegh, P., Boroumand, H., Ostadmohammady, F., Abbaszadeh‐Mashkani, S., Banafshe, H. R., Matini, A. H., Ghaderi, A., & Dehkohneh, S. G. (2022) · Brain and Behavior · doi:10.1002/brb3.2823 · Cited by 8 · see citing works

Reductions in tobacco use in naltrexone, relative to buprenorphine-maintained individuals with opioid use disorder: Secondary analysis from the National Drug Abuse Treatment Clinical Trials Network

Montgomery, L., Winhusen, T. M., Scodes, J. M., et al. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108489 · Cited by 7 · see citing works

Topiramate decreases the salience of motivationally relevant visual cues among smokers with alcohol use disorder

Robinson, J. D., Cui, Y., Karam‐Hage, M., Kypriotakis, G., Versace, F., Tiouririne, N. A., Anthenelli, R. M., & Cinciripini, P. M. (2022) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14771 · Cited by 7 · see citing works

Naltrexone and alcohol effects on craving for cigarettes in heavy drinking smokers.

Green, R., Bujarski, S., Lim, A. C., Venegas, A., & Ray, L. A. (2019) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000252 · Cited by 6 · see citing works

Role of modafinil in the treatment of patients with methamphetamine dependence; An update on randomized, controlled clinical trial

fard, M. T., Mansouri, S. S., Jafari, A., & Vousooghi, N. (2020) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v19i10.23 · Cited by 6 · see citing works

The Modulatory Effects of Atomoxetine on Aberrant Connectivity During Attentional Processing in Cocaine Use Disorder

Nestor, L. J., Luijten, M., Ziauddeen, H., Regenthal, R., Sahakian, B. J., Robbins, T. W., & Ersche, K. D. (2023) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2023.08.003 · Cited by 6 · see citing works

Results from a randomized controlled trial of zonisamide in the treatment of alcohol use disorder

Farchione, T. J., Long, L. J., Gallagher, M. W., Spencer-Laitt, D., Torre, M., Woodard, L. S., Curreri, A. J., Brown, B., Ross, M., & Barlow, D. H. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.08.044 · Cited by 5 · see citing works

A double-blind, randomized, placebo-controlled, pilot clinical trial examining buspirone as an adjunctive medication during buprenorphine-assisted supervised opioid withdrawal.

Bergeria, C. L., Tan, H., Antoine, D. G., et al. (2022) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000550 · Cited by 4 · see citing works

Effects of baclofen on insular gain anticipation in alcohol-dependent patients — a randomized, placebo-controlled, pharmaco-fMRI pilot trial

Pelz, P., Genauck, A., Lorenz, R. C., Wüstenberg, T., Wackerhagen, C., Charlet, K., Gleich, T., Geisel, O., Heinz, A., Müller, C. A., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06291-6 · Cited by 3 · see citing works

Treatment Use Among U.S. Adults with a Substance Use Disorder: Associations with Symptom Severity, Problem Self-Perception, Comorbid Mental Illness, and Mental Health Treatment

Choi, N. G., & Marti, C. N. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22040640 · Cited by 8 · see citing works

ИСПОЛЬЗОВAНИЕ ПОТЕНЦИAЛA СОЦИAЛЬНЫХ ПAРТНЕРОВ В ПОДГОТОВКЕ БУДУЩИХ ПЕДAГОГОВ

Атабекова, Б. Б. (2024) · Habaršy. Pedagogika ġylymdary seriâsy · doi:10.51889/2959-5762.2023.80.4.019

Susquehanna Chorale Spring Concert "Roots and Wings"

Hawkins, D. (2017)

Personality correlates and utilitarian judgments in the everyday context: Psychopathic traits and differential effects of empathy, social dominance orientation, and dehumanization beliefs

Takamatsu, R. (2019) · Personality and Individual Differences · doi:10.1016/j.paid.2019.03.029 · Cited by 22 · see citing works

Amount of altruistic punishment accounts for subsequent emotional gratification in participants with primary psychopathy

Masui, K., Iriguchi, S., Nomura, M., & Ura, M. (2011) · Personality and Individual Differences · doi:10.1016/j.paid.2011.07.006 · Cited by 14 · see citing works

Self-estimates of abilities are a better reflection of individuals’ personality traits than of their abilities and are also strong predictors of professional interests

Neubauer, A. C., & Hofer, G. (2020) · Personality and Individual Differences · doi:10.1016/j.paid.2020.109850 · Cited by 51 · see citing works